Deres P[au] - Search Results

Year	Number of Results
2002	1
2003	2
2004	1
2005	4
2006	2
2022	0

1

Myocardial protection by selective poly(ADP-ribose) polymerase inhibitors.

Kovacs K, Toth A, Deres P, Kalai T, Hideg K, Sumegi B. Kovacs K, et al. Among authors: deres p. Exp Clin Cardiol. 2004 Spring;9(1):17-20. Exp Clin Cardiol. 2004. PMID: 19641691 Free PMC article.

2

Akt activation induced by an antioxidant compound during ischemia-reperfusion.

Toth A, Halmosi R, Kovacs K, Deres P, Kalai T, Hideg K, Toth K, Sumegi B. Toth A, et al. Among authors: deres p. Free Radic Biol Med. 2003 Nov 1;35(9):1051-63. doi: 10.1016/s0891-5849(03)00467-2. Free Radic Biol Med. 2003. PMID: 14572608

3

Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound.

Deres P, Halmosi R, Toth A, Kovacs K, Palfi A, Habon T, Czopf L, Kalai T, Hideg K, Sumegi B, Toth K. Deres P, et al. J Cardiovasc Pharmacol. 2005 Jan;45(1):36-43. doi: 10.1097/00005344-200501000-00007. J Cardiovasc Pharmacol. 2005. PMID: 15613977

4

PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.

Palfi A, Toth A, Hanto K, Deres P, Szabados E, Szereday Z, Kulcsar G, Kalai T, Hideg K, Gallyas F Jr, Sumegi B, Toth K, Halmosi R. Palfi A, et al. Among authors: deres p. J Mol Cell Cardiol. 2006 Jul;41(1):149-59. doi: 10.1016/j.yjmcc.2006.03.427. Epub 2006 May 23. J Mol Cell Cardiol. 2006. PMID: 16716347

5

Impact of a novel cardioprotective agent on the ischaemia-reperfusion-induced Akt kinase activation.

Toth A, Kovacs K, Deres P, Halmosi R, Czopf L, Hanto K, Kalai T, Hideg K, Sumegi B, Toth K. Toth A, et al. Among authors: deres p. Biochem Pharmacol. 2003 Dec 1;66(11):2263-72. doi: 10.1016/j.bcp.2003.08.007. Biochem Pharmacol. 2003. PMID: 14609750

6

Extremely high maternal alkaline phosphatase serum concentration with syncytiotrophoblastic origin.

Boronkai A, Than NG, Magenheim R, Bellyei S, Szigeti A, Deres P, Hargitai B, Sumegi B, Papp Z, Rigo J Jr. Boronkai A, et al. Among authors: deres p. J Clin Pathol. 2005 Jan;58(1):72-6. doi: 10.1136/jcp.2003.015362. J Clin Pathol. 2005. PMID: 15623487 Free PMC article.

7

2,2,5,5-Tetramethylpyrroline-based compounds in prevention of oxyradical-induced myocardial damage.

Halmosi R, Deres P, Toth A, Berente Z, Kalai T, Sumegi B, Hideg K, Toth K. Halmosi R, et al. Among authors: deres p. J Cardiovasc Pharmacol. 2002 Dec;40(6):854-67. doi: 10.1097/00005344-200212000-00006. J Cardiovasc Pharmacol. 2002. PMID: 12451318

8

Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.

Kovacs K, Toth A, Deres P, Kalai T, Hideg K, Gallyas F Jr, Sumegi B. Kovacs K, et al. Among authors: deres p. Biochem Pharmacol. 2006 Feb 14;71(4):441-52. doi: 10.1016/j.bcp.2005.05.036. Epub 2005 Dec 6. Biochem Pharmacol. 2006. PMID: 16337154

9

The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.

Pálfi A, Tóth A, Kulcsár G, Hantó K, Deres P, Bartha E, Halmosi R, Szabados E, Czopf L, Kálai T, Hideg K, Sümegi B, Tóth K. Pálfi A, et al. Among authors: deres p. J Pharmacol Exp Ther. 2005 Oct;315(1):273-82. doi: 10.1124/jpet.105.088336. Epub 2005 Jun 10. J Pharmacol Exp Ther. 2005. PMID: 15951400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results